Research
Metabolic adaptation
Modest weight loss leads to improvements in glycemic levels, reducing the risk of diabetes-related complications and comorbidities.
Practitioners should encourage modest weight loss in obese T2D patients to improve glycemic control.
StrongSupportsmedium confidence
Studies have shown that modest weight loss leads to improvements in glycemic levels, thereby reducing the risk of diabetes-related complications and comorbidities.
Why this rating
The claim is supported by studies referenced in the abstract.
Source
Choice of Therapy in Obese Type 2 Diabetes
VivekaP Jyotsna et al. · Chronicle of Diabetes Research and Practice · 2022
DOI 10.4103/cdrp.cdrp_2_22
review
Read the paper DOI resolved against Crossref · corpus check 2026-06-10
More from this paper
- The first choice of therapy after lifestyle modification for T2D in obese individuals should be glucose-lowering agents that promote weight reduction or are weight neutral.Strong
- Therapies such as thiazolidinedione, insulin secretagogue, and insulin are less suitable for individuals with obesity and T2D as they are associated with weight gain.Strong
Related findings · Metabolic adaptation
This is one finding among thousands. Every one is graded and traced to its source, so you can see what the evidence actually supports. Browse the research →